Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Neuropathology and Applied Neurobiology

• Publication date

  1998-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-2990.1998.00137.xPMID 9821169
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amplification of the epidermal‐growth‐factor‐receptor gene correlates with different growth behaviour in human glioblastoma

  2007cited by this paper
• Brain tumors

  2007cited by this paper
• Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas

  2005cited by this paper
• Differential expression of cell adhesion molecules (CAM), neural CAM and epithelial cadherin in ependymomas and choroid plexus tumors

  2004cited by this paper
• Genetic alterations associated with the evolution and progression of astrocytic brain tumours

  2004cited by this paper
• Accumulation of genetic changes is associated with poor prognosis in grade II astrocytomas.

  1997cited by this paper
• Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value.

  1997cited by this paper
• Prognostic factors in malignant glioma: Influence of the overexpression of oncogene and tumor-suppressor gene products on survival

  1997cited by this paper
• Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas

  1997cited by this paper
• Overexpression of the EGF Receptor and p53 Mutations are Mutually Exclusive in the Evolution of Primary and Secondary Glioblastomas

  1996cited by this paper
• Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas.

  1996cited by this paper
• Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.

  1996cited by this paper
• EDITORIAL. p53—INTEGRATING THE COMPLEXITY

  1996cited by this paper
• p53--integrating the complexity.

  1996cited by this paper
• Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.

  1995cited by this paper
• The p53 gene and its role in human brain tumors

  1995cited by this paper
• Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.

  1994cited by this paper
• Expression of neural cell-adhesion molecule isoforms and epithelial cadherin adhesion molecules in 47 human meningiomas: correlation with clinical and morphological data.

  1994cited by this paper
• Alterations of the TP53 gene in human gliomas.

  1994cited by this paper
• p53 In tumour pathology: Can we trust immunohistochemistry?—revisited!

  1994cited by this paper
• Oncogenes and anti-oncogenes in human central nervous system tumors.

  1994cited by this paper
• The p53 Gene and Protein in Human Brain Tumors

  1994cited by this paper
• Quantitative imaging of estrogen and progesterone receptors, estrogen-regulated protein, and growth fraction: immunocytochemical assays in 52 meningiomas. Correlation with clinical and morphological data.

  1994cited by this paper
• The New WHO Classification of Brain Tumours

  1993cited by this paper
• Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation.

  1993cited by this paper
• Accumulation of wild type p53 protein in human astrocytomas.

  1993cited by this paper
• Regional Heterogeneity in the Proliferative Activity of Human Gliomas as Measured by the Ki‐67 Labeling Index

  1993cited by this paper
• Structural alterations of the epidermal growth factor receptor gene in human gliomas.

  1992cited by this paper
• Amplification of Epidermal Growth Factor Receptor Gene in Gliomas: Histopathology and Prognosis

  1992cited by this paper
• Expression of the p53 protein in a spectrum of astrocytic tumours

  1992cited by this paper
• Long‐Term Survival in Treated Anaplastic Astrocytomas: A Report of Combined RTOG/ECOG Studies

  1991cited by this paper
• The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas.

  1991cited by this paper
• Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki‐67 study

  1990cited by this paper
• Increased expression of mutant forms of p53 oncogene in primary lung cancer.

  1990cited by this paper
• Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma.

  1989cited by this paper
• Ki-67 detects a nuclear matrix-associated proliferation-related antigen. I. Intracellular localization during interphase.

  1989cited by this paper
• Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.

  1988cited by this paper
• Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling

  1988cited by this paper
• Gene Amplification in Malignant Human Gliomas: Clinical and Histopathologic Aspects

  1988cited by this paper
• Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin

  1985cited by this paper
• Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

  1984cited by this paper
• Expression of epidermal growth factor receptors in human brain tumors.

  1984cited by this paper
• CT prognostic criteria of survival after malignant glioma surgery.

  1983cited by this paper
• A nuclear antigen associated with cell proliferation and blast-transformation : its distribution in synchronized cells

  1982cited by this paper
• A nuclear antigen associated with cell proliferation and blast transformation

  1981cited by this paper
• A double scanning microphotometer for image analysis: hardware, software and biomedical applications.

  1979cited by this paper

• CRP/albumin ratio and WBC values correlate with Ki-67 and survival in glioblastoma multiforme

  2025cites this paper
• Non-invasive prediction of p53 and Ki-67 labelling indices and O-6-methylguanine-DNA methyltransferase promoter methylation status in adult patients with isocitrate dehydrogenase wild-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted

  2022cites this paper
• Implications of Cellular Immaturity in Necrosis and Microvascularization in Glioblastomas IDH-Wild-Type

  2022cites this paper
• Prognostic Effect of Immunohistochemical Scoring on Survival in Glioblastoma

  2022cites this paper
• Molecular and Circulating Biomarkers in Patients with Glioblastoma

  2022cites this paper
• Arterial Spin Labeling Perfusion in Determining the IDH1 Status and Ki-67 Index in Brain Gliomas

  2022cites this paper
• Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy

  2022cites this paper
• Is Ki-67 index overexpression in IDH wild type glioblastoma a predictor of shorter Progression Free survival? A clinical and Molecular analytic investigation.

  2020cites this paper
• Proliferative features of diffuse astrocytic tumors Grade III-IV and their impact on the prognosis

  2019cites this paper
• Cut‐point for Ki‐67 proliferation index as a prognostic marker for glioblastoma

  2019cites this paper
• Clinical significance of IDH1, EGFR, p53 and MIB1 in Astrocytoma Patients

  2019cites this paper
• Ki-67 labeling index in glioblastoma; does it really matter?

  2019cites this paper
• Analysis of frequency of alterations in EGFR exon 18-21 in Glioblastoma multiforme and its prognostic significance – A single centre experience from India

  2019cites this paper
• Immunohistochemical Expression of Epidermal Growth Factor Receptor in Astrocytic Tumors in Iraqi Patients

  2019cites this paper
• Phytanoyl-CoA 2-Hydroxylase-Interacting Protein-Like Gene Is a Therapeutic Target Gene for Glioblastoma Multiforme

  2019cites this paper
• EGFR as a clinical marker in glioblastomas and other gliomas

  2018cites this paper
• Prognostic significance of epidermal growth factor receptor expression in glioma patients

  2018cites this paper
• Prognostic and clinicopathological value of melanoma-associated antigen D4 in patients with glioma

  2018cites this paper
• Prognostic significance of epidermal growth factor receptor expression in glioma patients

  2018cites this paper
• Molecular pathological expression in malignant gliomas resected by fluorescein sodium-guiding under the YELLOW 560 nm surgical microscope filter

  2018cites this paper
• Clinicohistopathological study of astrocytomas along with Ki-67 proliferative index

  2018cites this paper
• Prognostic significance of epidermal growth factor receptor expression in glioma patients

  2018cites this paper
• Comparison of Pathological Indexes ( Ki-67 , p 53 ) , and Perfusion / Diffusion MR Parameters in Glioma Staging Gliom Evrelemesinde Patolojik İndekslerin ( Ki-67 , p 53 ) ve Perfüzyon / Difüzyon MR

  2018cites this paper
• The Methods Used in Nonparametric Covariance Analysis Parametrik Olmayan Kovaryans Analizinde Kullanılan Metotlar

  2018cites this paper
• Correlation between epidermal growth factor receptor and MIB-1 index in different grades of astrocytomas

  2017cites this paper
• Does Pretreatment Tumor Growth Hold Prognostic Information for Patients with Glioblastoma?

  2017cites this paper
• Étude de nouveaux facteurs pronostiques de la survie des patients atteints de glioblastome : mutation IDH et invasivité radiologique estimée par modélisation biophysique

  2016cites this paper
• Effect of epidermal growth factor receptor gene polymorphisms on prognosis in glioma patients

  2016cites this paper
• Ki-67 immunostaining in astrocytomas: Association with histopathological grade – A South Indian study

  2016cites this paper
• A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools.

  2015cites this paper
• EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy

  2014cites this paper
• Expression of phosphatase and tensin homolog, epidermal growth factor receptor, and Ki-67 in astrocytoma: A prospective study in a tertiary care hospital

  2014cites this paper
• Epidermal Growth Factor Receptor Is Related to Poor Survival in Glioblastomas: Single-Institution Experience

  2012cites this paper
• Pathology: commonly monitored glioblastoma markers: EFGR, EGFRvIII, PTEN, and MGMT.

  2012cites this paper
• Prognostic Significance of EGFR Gene Amplification and Overexpression in Diffuse Astrocytomas—A Literature Study

  2012cites this paper
• 14-3-3Zeta Positive Expression is Associated With a Poor Prognosis in Patients With Glioblastoma

  2011cites this paper
• Practical value of MIB-1 index in predicting behavior of astrocytomas.

  2011cites this paper
• Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments.

  2011cites this paper
• ErbB receptor signaling in astrocytes: a mediator of neuron-glia communication in the mature central nervous system.

  2010cites this paper
• Mining the Common Facts in Cancer : Reliability of Protein Expression in Breast Cancer and Brain Tumor

  2010cites this paper
• Gene expression profiles of human glioblastomas are associated with both tumor cytogenetics and histopathology.

  2010cites this paper
• Gliomas: correlation of histologic grade, Ki67 and p53 expression with patient survival.

  2010cites this paper
• Glioblastomes lioblastomes : facteurs pronostiques cliniques , radiologiques et biologiques lioblastoma : Clinical , radiological and biological prognostic factors

  2010cites this paper
• P53 immunoexpression as a prognostic marker for human astrocytomas: a meta-analysis and review of the literature

  2010cites this paper
• Factores pronósticos de supervivencia en pacientes mexicanos con glioblastoma multiforme

  2010cites this paper
• The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study.

  2010cites this paper
• eMedicine Specialties > Oncology > Carcinomas of the Central and Peripheral Nervous System

  2010cites this paper
• [Glioblastoma: clinical, radiological and biological prognostic factors].

  2010cites this paper
• Neurosphere Formation Is an Independent Predictor of Clinical Outcome in Malignant Glioma

  2009cites this paper
• Nachweis aktivierter intrazellulärer Signalwege in humanen glialen Tumoren durch Phosphorylierungs-spezifische Immunhistochemie

  2009cites this paper
• Prognostic factors other than the performance status and age for glioblastoma multiforme: a single-institution experience.

  2009cites this paper
• Imaging regional variation of cellular proliferation in gliomas using 3'-deoxy-3'-[18F]fluorothymidine positron-emission tomography: an image-guided biopsy study.

  2009cites this paper
• Eukaryotic Initiation Factors (eIF) 2α and 4E Expression, Localization, and Phosphorylation in Brain Tumors

  2009cites this paper
• Comparative immunohistochemical analysis of aurora-A and aurora-B expression in human glioblastomas. Associations with proliferative activity and clinicopathological features.

  2009cites this paper
• Rôle de la voie de signalisation Interleukine-6 dans la radiorésistance des glioblastomes humains

  2009cites this paper
• Prognosis of glioma patients by combined immunostaining for survivin, Ki-67 and epidermal growth factor receptor.

  2008cites this paper
• Epidermal growth factor receptor and proliferating cell nuclear antigen in astrocytomas.

  2008cites this paper
• Epidermal Growth Factor Receptor Serum Levels and Prognostic Value in Malignant Gliomas

  2007cites this paper
• Coexpression of c-erbB 1-4 receptor proteins in human glioblastomas. An immunohistochemical study.

  2007cites this paper
• Hyperprolactinemia and immunohistochemical expression of intracellular prolactin and prolactin receptor in primary central nervous system tumors and their relationship with cellular replication

  2007cites this paper
• Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.

  2006cites this paper
• Prognosis of cerebellar glioblastomas: correlation between prognosis and immunoreactivity for epidermal growth factor receptor compared with supratentorial glioblastomas.

  2006cites this paper
• p53 expression, Ki-67 status, and cell density have no prognostic significance in glioblastomas treated with radio-chemotherapy

  2006cites this paper
• Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177.

  2006cites this paper
• Lack of alkaline phosphatase activity predicts meningioma recurrence.

  2005cites this paper
• Morphology of Tumor Cell Nuclei Is Significantly Related with Survival Time of Patients with Glioblastomas

  2005cites this paper
• Prognostic Effect of Epidermal Growth Factor Receptor and EGFRvIII in Glioblastoma Multiforme Patients

  2005cites this paper
• The natural history of EGFR and EGFRvIII in glioblastoma patients

  2005cites this paper
• Epidermal growth factor receptor in glioblastoma.

  2005cites this paper
• Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.

  2005cites this paper
• Role of MIB1 in Predicting Survival in Patients with Glioblastomas

  2005cites this paper
• [Towards a molecular classification of gliomas].

  2005cites this paper
• Genetic analyses for predictors of radiation response in glioblastoma.

  2005cites this paper
• Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology Group.

  2005cites this paper
• Einfluss der Radikalität der Resektion eines Glioblastoma multiforme in Kombination mit einer adjuvanten Chemotherapie auf das Survival

  2005cites this paper
• Gene Expression Profiling of Gliomas Strongly Predicts Survival

  2004cites this paper
• Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.

  2004cites this paper
• EGF‐R and PDGF‐R, but not bcl‐2, overexpression predict overall survival in patients with low‐grade astrocytomas

  2004cites this paper
• Ki-67 Labeling is Correlated with the Time to Recurrence in Primary Glioblastomas

  2004cites this paper
• Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

  2003cites this paper
• Patients with Glioblastoma Multiforme Prognostic Value of Epidermal Growth Factor Receptor in Updated

  2003cites this paper
• Spinal cord malignant astrocytomas

  2003cites this paper
• Age-related Expression of p53, Mdm2, EGFR and Msh2 in Glioblastoma Multiforme

  2003cites this paper
• Loss of heterozygosity of a locus in the chromosomal region 17p13.3 is associated with increased cell proliferation in astrocytic tumors.

  2003cites this paper
• De novo cerebellar medulloblastoma in a 26-year recurrence-free case of temporal glioblastoma multiforme. Case report.

  2003cites this paper
• Ki-67 immunoreactivity, basic fibroblastic growth factor (bFGF) expression, and microvessel density as supplementary prognostic tools in low-grade astrocytomas. An immunohistochemical study with special reference to the reliability of different Ki-67 antibodies.

  2002cites this paper
• Radiosensitivity and TP53, EGFR Amplification and LOH10 Analysis of Primary Glioma Cell Cultures

  2002cites this paper
• Prognostic Factors in Long-Term Survivors with Glioblastoma

  2002cites this paper
• Immunohistochemically Detected p53 Mutations in Epithelial Tumors and Results of Treatment with Chemotherapy and Radiotherapy A Treatment-Specific Overview of the Clinical Data

  2002cites this paper
• High expression of DNA topoisomerase IIalpha and Ki-67 antigen is associated with prolonged survival in glioblastoma patients.

  2002cites this paper
• Immunohistochemical Markers for Prognosis of Cerebral Glioblastomas

  2002cites this paper
• Proliferative marker Ki-67 in gallbladder carcinomas: high expression level predicts early recurrence after surgical resection.

  2002cites this paper
• Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies.

  2002cites this paper
• PAI-1 and EGFR expression in adult glioma tumors: toward a molecular prognostic classification.

  2002cites this paper
• Vestibular Schwannomas: Correlations Between Magnetic Resonance Imaging and Histopathologic Appearance

  2001cites this paper
• The Prognostic Value of Tumor Markers in Patients with Glioblastoma Multiforme: Analysis of 32 Patients and Review of the Literature

  2001cites this paper
• Proliferative activity in human glioblastomas assessed by various techniques

  2001cites this paper
• Interobserver variability associated with the MIB‐1 labeling index

  2001cites this paper
• EGFR overexpression and radiation response in glioblastoma multiforme.

  2001cites this paper
• Phase I Clinical Evaluation of a Neutralizing Monoclonal Antibody Against Epidermal Growth Factor Receptor in Advanced Brain Tumor Patients: Preliminary Study

  2001cites this paper